BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+8.76%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.27B
AUM Growth
+$3.27B
(+7%)
Cap. Flow
+$8.33M
Cap. Flow
% of AUM
0.25%
Top 10 Holdings %
Top 10 Hldgs %
74.79%
Holding
30
New
–
Increased
16
Reduced
6
Closed
2
Top Buys
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$22.5M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$15.2M |
| 3 |
Neurocrine Biosciences
NBIX
|
$11.3M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$7.47M |
| 5 |
Halozyme
HALO
|
$6.61M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$31.9M |
| 2 |
CELG
Celgene Corp
CELG
|
$11.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
$10.4M |
| 4 |
Puma Biotechnology
PBYI
|
$9.14M |
| 5 |
PTC Therapeutics
PTCT
|
$6.72M |
Sector Composition
| 1 | Healthcare | 89.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Incyte
INCY
$16.5B
| $443M | 13.53% | 3,514,822 +25,000 | +0.7% | +$3.15M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $422M | 12.9% | 3,249,298 -90,000 | -3% | -$11.7M |
|
3
Ionis Pharmaceuticals
IONS
$6.8B
| $374M | 11.43% | 7,354,095 -107,200 | -1% | -$5.45M |
|
|
RDUS
4
DELISTED
Radius Health, Inc.
RDUS
| $228M | 6.97% | 5,038,799 +498,400 | +11% | +$22.5M |
|
5
Gilead Sciences
GILD
$140B
| $196M | 6% | 2,774,596 | – | – |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $190M | 5.81% | 1,475,445 +20,000 | +1% | +$2.58M |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $165M | 5.04% | 1,354,428 +125,000 | +10% | +$15.2M |
|
|
8
Neurocrine Biosciences
NBIX
$13.8B
| $159M | 4.85% | 3,446,552 +245,000 | +8% | +$11.3M |
|
9
Agios Pharmaceuticals
AGIO
$2.19B
| $148M | 4.51% | 2,869,528 +30,000 | +1% | +$1.54M |
|
|
TSRO
10
DELISTED
TESARO, Inc.
TSRO
| $123M | 3.75% | 877,990 +53,408 | +6% | +$7.47M |
|
|
11
Halozyme
HALO
$8.56B
| $106M | 3.24% | 8,265,304 +515,472 | +7% | +$6.61M |
|
12
Alnylam Pharmaceuticals
ALNY
$58.5B
| $97.4M | 2.98% | 1,221,338 -20,000 | -2% | -$1.6M |
|
|
13
Regeneron Pharmaceuticals
REGN
$61.5B
| $88.4M | 2.7% | 180,000 -65,000 | -27% | -$31.9M |
|
|
SAGE
14
DELISTED
Sage Therapeutics
SAGE
| $72.3M | 2.21% | 907,439 -65,000 | -7% | -$5.18M |
|
15
Esperion Therapeutics
ESPR
$448M
| $70M | 2.14% | 1,513,542 +105,000 | +7% | +$4.86M |
|
|
KITE
16
DELISTED
Kite Pharma, Inc.
KITE
| $66.3M | 2.03% | 640,000 -100,000 | -14% | -$10.4M |
|
|
JUNO
17
DELISTED
Juno Therapeutics, Inc.
JUNO
| $65.3M | 2% | 2,185,000 | – | – |
|
18
MacroGenics
MGNX
$112M
| $41.2M | 1.26% | 2,350,112 +90,112 | +4% | +$1.58M |
|
|
MYOV
19
DELISTED
Myovant Sciences Ltd.
MYOV
| $38.8M | 1.19% | 3,317,171 +14,336 | +0.4% | +$168K |
|
|
AVXS
20
DELISTED
AveXis, Inc. Common Stock
AVXS
| $33.1M | 1.01% | 402,800 +70,000 | +21% | +$5.75M |
|
|
ICPT
21
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $31M | 0.95% | 255,719 | – | – |
|
|
ITCI
22
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $26.7M | 0.82% | 2,150,000 +225,000 | +12% | +$2.79M |
|
|
FPRX
23
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $23.4M | 0.72% | 777,500 +50,000 | +7% | +$1.51M |
|
|
ALDR
24
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $22.2M | 0.68% | 1,941,008 +255,858 | +15% | +$2.93M |
|
25
Prothena Corp
PRTA
$441M
| $18.9M | 0.58% | 350,000 | – | – |
|